Multiplexed Diagnostics Market Expected to Reach USD 9.8 Billion Globally in 2019: Transparency Market Research
Albany, New York (PRWEB) August 20, 2014
According to a new market report published by Transparency Market Research "Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays& Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", the global multiplexed diagnostics market was valued at USD 2.8 billion in 2012 and is expected to grow at a CAGR of 19.4%from 2013 to 2019, to reach an estimated value of USD 9.8 billion in 2019.
Browse Global Multiplexed Diagnostics Market Report with Full TOC: http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
Multiplexed diagnostics market is one of the fastest growing segments in the diagnostics market. Factors such as increasing demand for rapid diagnostic tools that can simultaneously screen multiple analyses in a single cycle of the assay, high prevalence of infectious diseases and cardiac diseases worldwide and inability of conventional diagnostic tools to give accurate and reliable results in lesser turnaround time will have a tremendous impact on the growth of the multiplexed diagnostics industry.
The global multiplexed diagnostics market is segmented on the basis of types of technology, application area and geography. Based on this, the multiplexed diagnostics market is classified into very high density multiplexed assays, high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays and next-generation sequencing. In addition, this market is also segmented on the basis of applications such as infectious disease diagnosis, oncology, autoimmune diseases, cardiac, allergies and others. Next-generation sequencing is rapidly replacing other technologies available in the multiplexed diagnostics market due to its capability of screening analyses ranging from low to high density using same instrument at a much cheaper cost. Furthermore, it is expected that the global market for next-generation sequencing will reach USD 1.96 billion in 2019 growing at a CAGR of 39.1%from 2013 to 2019.
The North American region currently leads the multiplexed diagnostics market due to advantage of the early launch of ground-breaking technologies in this region.Factors that currently drive the growth of the North American multiplexed diagnostics market include existence of supportive economic base particularly in terms of high disposable income, significant awareness about available multiplexed diagnostic technologies and better adoption rate. However,countries in the Asia-Pacific region such as Japan, China and India are reported to be emerging markets with development of healthcare infrastructure, rapidly growing medical tourism industry and high prevalence of infectious diseases and aging of population leading to rise in the incidence of cardiac diseases and rapidly increasing healthcare awareness. Furthermore, apart from Argentina, Mexico and Brazil, Egypt and African countries are some of the lucrative markets for multiplexed diagnostics in the Rest of the World.
The global multiplexed diagnostics market has a limited number of market players thus resulting in market consolidation and high competitive rivalry. Some of the key participants operating in this market includeAffymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Life Technologies, Luminex Corporation and Illumina, Inc.
Related & Recently Published Reports by Transparency Market Research
Vinyl Acetate Monomer (VAM) Market: http://www.transparencymarketresearch.com/vinyl-acetate-monomer-market.html
Global Spectrometry Market: http://www.transparencymarketresearch.com/spectrometry-market.html
The global multiplexed diagnostics market is segmented as follows:
Multiplexed Diagnostics Market, by Technology
- Very High Density Multiplexed Assays
- Oligonucleotide Arrays
- Phage Display
- High Density Multiplexed Assays
- Bacterial Artificial Chromosome Arrays
- Protein Arrays
- Medium Density Multiplexed Assays
- Bead-based Arrays
- Antibody Arrays
- Reverse Arrays
- Mass Spectroscopy
- Low Density Multiplexed Arrays
- Quantitative PCR Bead-based Assays
- Microplate Assays
- Next-Generation Sequencing
For Further Inquiries, Ask Here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719
Multiplexed Diagnostics Market, by Application
- Infectious Disease Diagnosis
- Autoimmune diseases
Multiplexed Diagnostics Market, by Geography
- North America
- Rest of the World (RoW)
90 Sate Street, Suite 700
Albany, NY 12207
USA/Canada Toll Free: 866-552-3453
Follow us on Facebook https://www.facebook.com/transparencymarketresearch